| INTRODUCTION
Intellectual disability (ID) has a prevalence of 1-3% in population and can result from heterogeneous causes like environmental/ nutritional effect, chromosomal or monogenic causes (Maulik, Mascarenhas, Mathers, Dua, & Saxena, 2011) . More than 230 genes have been reported to be involved in causation of syndromes of intellectual disability. Mental retardation, ptosis, and polydactyly are a distinctive combination of clinical features reported by us. This is a rare type of intellectual disability syndrome, reported only in a single consanguineous family from India, where three individuals were affected (Panigrahi, Phadke, & Agarwal, 2002) .
ID, short stature, and polydactyly was suggestive of possibility of Bardet Biedl syndrome (BBS, MIM: 209900), but absence of obesity, renal abnormality, retinopathy, and normal sexual development were some of the phenotypes that were different from BBS.
Another possibility was 3MC syndrome, which was formally known as Carnevale syndrome (MIM: 265050), however patients did not had hip dysplasia, cryptorchidism, and abdominal muscle defect.
For identification of candidate gene in this family we have employed homozygosity mapping followed by exome sequencing in all the three affected siblings with mental retardation, ptosis, and polydactyly phenotype.
| MATERIALS AND METHODS

| Clinical report
We described the clinical features in three affected siblings born out of consanguineous union, characterized as mental retardation, ptosis, and polydactyly phenotype (Panigrahi et al., 2002) . The proband showed severe intellectual disability (ID), bilateral ptosis, downslanting palpebral fissures, hypertelorism, round face, high arched palate, clinodactyly, tapering of fingers, and hypermobile patellae (Figure 1c) .
He also had joint laxity in the metacarpophalangeal and interphalangeal joints in hands and short stature. Female sibling was also proportionately short with stocky build. She had moderate ID, ptosis in right eye, pointed chin, bilateral post axial polydactyly with joint laxity.
The third male sibling had marked joint laxity similar to proband, moderate ID, bilateral ptosis, and bilateral post axial polydactyly (Table 1) . We collected blood samples from all affected siblings and both parents after informed consent. This study was approved by the Institutional Ethics Committee.
| Genetic analysis
Genomic DNA from all affected and unaffected family members was extracted from whole blood. SNP array analysis in all three affected individuals was performed by using Illumina Human-CytoSNP-12 v.2.1 DNA Analysis BeadChip Kit (Illumina Inc., San Diego, CA).
Analysis of array data was performed using Genome studio software. Size threshold for analysis was kept as 200 kb for deletion, 500 kb for duplication, and 1 Mb for homozygous regions.
Genomic Oligoarray and SNP evaluation tool (v3.0) (http://firefly. ccs.miami.edu/cgi-bin/ROH/ROH_analysis_tool.cgi) was used for detection of known disease causing OMIM genes in the common homozygous regions.
Exome sequencing was performed in all three affected sibs.
Agilent SureSelectXT V5 exome capture kit (Agilent Technologies, Santa Clara, CA) was used for preparation of exome library by using ∼3 μg of genomic DNA. Exome library was sequenced to mean 100× coverage on Illumina HiSeq2000 sequencing platform. Alignment to human reference genome (GRCh37/hg19) and variant calling were performed using NEXTGENe v.2.3.4.4 (SoftGenetics, LLC, State College, PA) followed by variant annotation by ANNOVAR (Wang, Li, & Hakonarson, 2010 
| In vivo analysis of variant at splice site
An observed variation was evaluated for splicing defect using pCAS2 minigene construct (Tournier et al., 2008) . Wild-Type (ARMC9_Wt) and mutant (ARMC9_Mt) constructs were created by PCR amplification from control and patient sample, respectively, followed by cloning them in BamH I and Mlu I restriction site of pCAS2 vector. Recombinant constructs as well as pCAS2 (as control) were transfected into COS7 cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cells were harvested after 18 hr of transfection and total RNA was extracted from each transfectant using RNeasy Mini Kit (Qiagen, Hilden, Germany), as per the manufacturer's instruction. Total RNA was subjected to RT PCR using SuperScript III (Invitrogen) followed by plasmid specific amplification (P1 and P2 primer) and evaluated on 2% agarose gel. Appropriate bands were purified using QIAquick Gel Extraction Kit (Qiagen) and subjected to Sanger sequencing using on ABI3130 Genetic analyzer (Life Technologies).
| Molecular modelling
To analyze conservation pattern of ARMC9 (NP_001278585), protein sequences from various species were aligned. Multiple sequence alignment was performed for the region of ARM domain I, which is expected to be affected during splicing event using ClustalW software (http://embnet.vital-it.ch/software/ClustalW. html). An ARMC9 wild-type (1-665 aa) and ARMC9 mutant structural model was generated using I-TASSER software (http:// zhanglab.ccmb.med.umich.edu/I-TASSER/) for comparison of predicted molecular structures (Roy, Kucukural, & Zhang, 2010; Yang et al., 2015; Zhang, 2008) .
| Homozygosity mapping and exome sequencing
We did not identify any significant copy number variations in any of the affected siblings. Regions of loss of heterozygosity (LOH) greater than 1 MB shared by affected siblings were identified on chromosome 2, 7, 10, and 14 (Supplementary Table S2 c.879G>A in ARMC9) present in shared homozygous region of 11 Mb on Chromosome 2 were studied further (Table 2 and Supplementary   Table S3 ).
The variant in UGT1A7 was predicted to be pathogenic but the 
| Characterization of variant by minigene assay for splicing defect
Since ARMC9 is not expressed in blood, in vivo characterization of this variant was done to determine whether it causes a defect in mRNA splicing using pCAS2 minigene. PCR amplification using pCAS2 minigene specific primers (P1 and P2) from cDNA prepared using all transfectants were checked on 2% agarose gel, which revealed presence of 255 bp band in PCAS (control plasmid) and ARMC9_Mt whereas ARMC9_Wt had 354 bp fragment (Figure 2 ).
These results indicate that the variant is likely to lead to skipping of exon during splicing event. To confirm the results from RNA assay, sequencing of specific bands form RT-PCR for ARMC9_pCAS_Wt and ARMC9_pCAS_Mt was done by Sanger sequencing, which revealed deletion of 99 base pairs of exon 9 of ARMC9 gene (Supplementary Figure S1 ). This result confirms that synonymous variant c.879G>A
(p.T293T) leads to abolition of splice site and leads to skipping of exon 9 of ARMC9 which may result in in-frame deletion of 33 amino acids (exon 9) form ARMC9 in patients.
Multiple sequence alignment of ARMC9 across vertebrates and invertebrates shows that ARM domains are highly conserved across species. Structural modelling of ARMC9 predicts similar structure to other ARM domain containing proteins such as beta-catanin, which shows presence of superheilx of alpha helices with three helices per unit, this forms a grove, which presumably may interact with its partners. ARMC9 mutant structure indicates deletion of 261-293 aa residues from wild-type ARMC9 critically disrupts its structure and hence may abolish native function of ARMC9 (Figure 3 ).
| DISCUSSION
We elucidated the molecular basis in three siblings who were diagnosed with mental retardation, ptosis, and polydactyly phenotype, using homozygosity mapping and whole exome sequencing. Whole exome sequencing analysis revealed a homozygous synonymous splice site variant in ARMC9 gene (c.879G>A) in these patients. This variant leads to abolition of splice site, which leads to skipping of exon 9 during splicing event.
Intellectual disability in combination with other clinical features represents a heterogeneous group of genetic disorders with large number of causal genes (Vissers, Gilissen, & Veltman, 2016) .
Combination of homozygosity mapping and exome sequencing has allowed us to examine small family with few affected individuals, particularly in the case of recessive mode of inheritance and consanguinity, to efficiently limit the number of candidate genes to be studied and establish new disease-gene association.
ARMC9 was first reported in cDNA analysis of human fetal whole brain, which revealed expression of several new long coding transcripts.
One of them was ARMC9, which was reported as KIA1868 (Nagase, Nakayama, Nakajima, Kikuno, & Ohara, 2001) . ARMC9 is also known as Lish domain containing protein ARMC9, NS21, and Melanoma/melanocyte specific tumor antigen KU-MEL-1 (Kiniwa et al., 2001 ). ARMC9 is a lesser known protein, containing N-termina l LisH (Lissencephaly type 1like homology) domain and C-terminal ARM (Armadillo repeats) motifs. Proteins containing LisH domains are known to be involved in microtubule dynamics and cell division (Gerlitz, Darhin, Giorgio, Franco, & Reiner, 2005) . Armadillo (ARM) repeats are characterized as repeating, 42 amino acid motifs, composed of three α helices. Although ARM repeat containing proteins do not share sequence | 37 similarity, they share a similar structure (Tewari, Bailes, Bunting, & Coates, 2010) . Multiple ARM repeats fold together to form a super-helix structure, which acts as platform for interaction with protein partners.
ARM containing proteins are conserved through eukaryotes and are involved in diverse cellular functions such as signal transduction, cell migration, and proliferation and cytoskeletal regulation (Coates, 2003; Valenta, Hausmann, & Basler, 2012 (Rolland et al., 2014) , which indicates that ARMC9 may be involved in ubiquitination pathway like ARMC8 (Tomaru et al., 2010) .
To study effect of mutation in splicing, the best method is analysis of patient RNA for respective gene, but ARMC9 has little or no expression in adult tissue (Kiniwa et al., 2001 ). Thus we proceeded with alternate method for assay of splicing defect using PCAS2 miningene system. Synonymous splicing defect variant, which leads to skipping of exon 9 in ARMC9 gene will lead to in-frame deletion of few ARM disorders (ID with syndromic features) (Ligt et al., 2012; WinczewskaWiktor et al., 2016) . Studies on mouse mutant that carries mutation in armadillo repeat of Beta catenin (CTNNB1) demonstrate reduced affinity for membrane associated cadherins (Tucci et al., 2014) . Similarly mutation in APC2, an ARM containing protein involved in neural development, is associated with Sotos syndrome 3 (MIM: 61719) involving ID, hyperactive behavior with macrocephaly (Almuriekhi et al., 2015) . Thus ARMC9 also is likely to be involved in neurodevelopmental process and its perturbation may lead to syndromic ID.
Recent study revealed mutation in ARMC9 Leads to Joubert syndrome 30 (JS30; MIM:617622) in human and ciliopathy features in Zebrafish (Weghe et al., 2017) . The study shows that ARMC9 Localizes to basal body and may be involved in ciliary machinery. In Zebrafish CRISPR-engineered armc9 shows reduction of cilia in brain ventricles, curved body, and coloboma similar to other ciliopathy associated genes. Further investigation on our patients also showed molar tooth sign and absence of cerebellar vermis, key phenotypes of Joubert Syndrome (Figure 1d-f) .
In summary, here we report on a synonymous splice site variant in ARMC9 as a cause of Joubert syndrome in the family. The variant affects conserved ARM repeats at the C terminus and is likely to disrupt its interaction with other protein partners. ARMC9 joins an important group of highly conserved ARM repeat containing proteins associated with intellectual disability which includes Beta Catenin (CTNNB1), APC2.
Revelation of mutation in ARMC9 Leads to JS30, extends the genetic heterogeneity of JS and expands gene list for ciliopathies. The exact nature and essential role of ARMC9 remains to be fully characterized, however these results further expand our understanding of molecular genetic basis of intellectual disability and facilitate better counseling of patients.
